Randomised controlled trials (RCTs) are considered the gold standard for studying the safety and efficacy of new interventions and are generally required by regulatory bodies for approval of new therapies. RCTs reduce bias by controlling both known and unknown confounding factors through random assignment of participants to the intervention under investigation or the control. The […]
EMVision Medical Devices reports encouraging progress in stroke-related brain scan trial
Australia is already an attractive location to host clinical trials with an efficient ethics and regulatory framework, diverse participant recruitment pool and high-quality research facilities just a few of the drawcards. Clinical trials contribute over $1.1bn annually to the Australian economy; so, it is no wonder the council of Australian Governments (COAG) Health Council is […]
Services are often outsourced to third party vendors for certain clinical trial activities, particularly where a clinical trial activity must be standardised. Such vendor services can include a centralised review of imaging data, central pathology or laboratory analysis and Investigational Product logistics. Following the decision to outsource a service to a third-party vendor for a […]
AusTrade’s latest Clinical Trials Capability Report has some interesting facts n figures Between 2012 and 2015, phase I activity has grown by 17.2% in Australia, compared to 1.8% globally Between 2012 and 2015, phase I activity has grown by 17.2% in Australia, compared to 1.8% globally In early phase clinical trials, Australia is 28% cheaper […]
We are please to report that AbilityMate has won the 2017 National Disability Excellence in Innovation Award “We’re living in an era of design where human invention, empowered by technology could reshape the lives of people with disabilities for the better.” Melissa Fuller, co-founder AbilityMate AbilityMate is a social enterprise that combines the power of […]
The Directors of Mobius Medical attended Medtech’s Got Talent Gala Dinner last week to listen to thirteen semi-finalists pitch their incredible ideas to a well dressed and excited audience. Delighted to be on the table of one of the winners, Murray McDonald of MUVi as well as their mentors from D+I, they felt like winners […]
Forty-five per cent of patients in Dimerix’s (ASX:DXB) successful Phase 2a trial in chronic kidney disease (CKD), on advice from their physician, applied for and were granted access to remain on DMX-200 under Australia’s Special Access Scheme, which allows participants continued access to a therapy after they complete a clinical study. Read the complete story […]
What is Risk Based Monitoring? Risk based monitoring is a new monitoring model that has been accepted by the European Medicines Agency and the Food and Drug Administration. It is an innovative risk based approach that focuses on critical study parameters and relies on a combination of monitoring and analytics to oversee patient safety and […]
Mobius Medical, like many other CROs all over the world, is privileged to be involved in the development of a myriad of novel innovations, and life changing medical devices, diagnostic tools and medicines. We are in the business of providing clinical trials management, strategic advice and digital solutions to the inventors and manufacturers of these […]